Back
Brainstorm Cell Therapeutics Stock Price Chart
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
44
BCLI
Brainstorm Cell Therapeutics
Last Price:
$1.26
Seasonality Move:
21.78%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCLI is experiencing slight selling pressure.
Brainstorm Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Buy |
| 20-day SMA: | 1.15 | Buy |
| 50-day SMA: | 1.11 | Buy |
| 200-day SMA: | 1.84 | Sell |
| 8-day EMA: | 1.19 | Buy |
| 20-day EMA: | 1.18 | Buy |
| 50-day EMA: | 1.2 | Buy |
| 200-day EMA: | 2.44 | Sell |
Brainstorm Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 52.91 | Buy |
| Chaikin Money Flow: | -31209 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.09 - 1.25) | Buy |
| Bollinger Bands (100): | (1.04 - 1.68) | Sell |
Brainstorm Cell Therapeutics Technical Analysis
| Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics Stock
Is Brainstorm Cell Therapeutics Stock a Buy?
-
Brainstorm Cell Therapeutics share price is 1.21 while BCLI 8-day simple moving average is 1.21, which is a Buy signal.
-
The stock price of BCLI is 1.21 while Brainstorm Cell Therapeutics 20-day SMA is 1.15, which makes it a Buy.
-
Brainstorm Cell Therapeutics 50-day simple moving average is 1.11 while BCLI share price is 1.21, making it a Buy technically.
-
BCLI stock price is 1.21 and Brainstorm Cell Therapeutics 200-day simple moving average is 1.84, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
44
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy or a Sell?
-
Brainstorm Cell Therapeutics stock is rated a SellThe current Brainstorm Cell Therapeutics [BCLI] share price is $1.21. The Score for BCLI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics Stock Info
Market Cap:
9.6M
Price in USD:
1.21
Share Volume:
277.8K
Brainstorm Cell Therapeutics 52-Week Range
52-Week High:
6.94
52-Week Low:
0.72
Sell
44
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Brainstorm Cell Therapeutics Share Price Forecast
-
What is the Brainstorm Cell Therapeutics stock price today?The Brainstorm Cell Therapeutics stock price is 1.21 USD today.
-
Will BCLI stock go up or go down?Brainstorm Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Brainstorm Cell Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics is overvalued.
Is Brainstorm Cell Therapeutics Stock a Buy?
-
Brainstorm Cell Therapeutics share price is 1.21 while BCLI 8-day exponential moving average is 1.19, which is a Buy signal.
-
The stock price of BCLI is 1.21 while Brainstorm Cell Therapeutics 20-day EMA is 1.18, which makes it a Buy.
-
Brainstorm Cell Therapeutics 50-day exponential moving average is 1.20 while BCLI share price is 1.21, making it a Buy technically.
-
BCLI stock price is 1.21 and Brainstorm Cell Therapeutics 200-day simple moving average is 2.44, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics
Is Brainstorm Cell Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.23 per share, an increase this year of $0.50 per share, and an increase next year of $0.16 per share.
Technical Analysis of Brainstorm Cell Therapeutics
Should I short Brainstorm Cell Therapeutics stock?
-
BCLI Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Brainstorm Cell Therapeutics is a Buy
-
Brainstorm Cell Therapeutics Relative Strength Index (RSI) is 52.91, which suggest Brainstorm Cell Therapeutics is overbought
-
The Bollinger Bands (25) for Brainstorm Cell Therapeutics is (1.09 - 1.25), which suggest Brainstorm Cell Therapeutics is a Sell
-
The Bollinger Bands (100) for Brainstorm Cell Therapeutics is (1.04 - 1.68), which suggest Brainstorm Cell Therapeutics is a Sell
* Brainstorm Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.